Juliel Espinosa

Juliel Espinosa

Auto-generated profile, based on publicly available information

Juliel Espinosa

Laboratory of Chemical Biology and Microbial Pathogenesis, The Rockefeller University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Science
Verified
Journal Article
Closed access
MGMatthew E. Griffin
Matthew E. Griffin
JEJuliel Espinosa
Juliel Espinosa
JBJessica L. Becker
Jessica L. Becker
JLJi-Dung Luo
Ji-Dung Luo
TCThomas S. Carroll
Thomas S. Carroll
HHHoward C. Hang
Howard C. Hang
SagA promotes immunotherapy response: The gut microbiome can influence the treatment outcome for cancer patients receiving PD-L1 immunotherapy, but the mechanisms underlying favorable responses are unclear. Griffinet al. found that a particular type of bacteria called enterococci enhance anti–PD-L1 immunotherapy in mice (see the Perspective by Ansaldo and Belkaid). The researchers show that enterococci secrete an enzyme called SagA that breaks down components of the bacterial cell wall. This process results in the release of muramyl peptide fragments, which in turn act as stimulatory molecules to promote signaling of the innate immune sensor protein NOD2 and improved immunotherapy responses. —PNK

10 April 2019 in eLife
Verified
Journal Article
Open access
BKByungchul Kim
Byungchul Kim
YWYen-Chih Wang
Yen-Chih Wang
CHCharles W Hespen
Charles W Hespen
JEJuliel Espinosa
Juliel Espinosa
JSJeanne Salje
Jeanne Salje
HHHoward C. Hang
Howard C. Hang
We discovered that Enterococcus faecium (E. faecium), a ubiquitous commensal bacterium, and its secreted peptidoglycan hydrolase (SagA) were sufficient to enhance intestinal barrier function and pathogen tolerance, but the precise biochemical mechanism was unknown. Here we show E. faecium has unique peptidoglycan composition and remodeling activity through SagA, which generates smaller muropeptides that more effectively activates nucleotide-binding oligomerization domain-containing protein 2 (NOD2) in mammalian cells. Our structural and biochemical studies show that SagA is a NlpC/p60-endopeptidase that preferentially hydrolyzes crosslinked Lys-type peptidoglycan fragments. SagA secretion and NlpC/p60-endopeptidase activity was required for enhancing probiotic bacteria activity against Clostridium difficile pathogenesis in vivo. Our results demonstrate that the peptidoglycan composition and hydrolase activity of specific microbiota species can activate host immune pathways and enhance tolerance to pathogens.

2 November 2020 in Biochemistry
Verified
Journal Article
Closed access
JEJuliel Espinosa
Juliel Espinosa
TLTi-Yu Lin
Ti-Yu Lin
YEYadyvic Estrella
Yadyvic Estrella
BKByungchul Kim
Byungchul Kim
HMHenrik Molina
Henrik Molina
HHHoward C. Hang
Howard C. Hang

20 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
MGMatthew E. Griffin
Matthew E. Griffin
JEJuliel Espinosa
Juliel Espinosa
JBJessica L. Becker
Jessica L. Becker
JJJyoti K. Jha
Jyoti K. Jha
GFGary R. Fanger
Gary R. Fanger
HHHoward C. Hang
Howard C. Hang
The antitumor efficacy of cancer immunotherapy has been correlated with specific species within the gut microbiota. However, molecular mechanisms by which these microbes affect host response to immunotherapy remain elusive. Here we show that specific members of the bacterial genus Enterococcus can promote anti-PD-L1 immunotherapy in mouse tumor models. The active enterococci express and secrete orthologs of the NlpC/p60 peptidoglycan hydrolase SagA that generate immune-active muropeptides. Expression of SagA in non-protective E. faecalis was sufficient to promote antitumor activity of clinically approved checkpoint targets, and its activity required the peptidoglycan sensor Nod2. Notably, SagA-engineered probiotics or synthetic muropeptides also promoted checkpoint inhibitor antitumor activity. Our data suggest that microbiota species with unique peptidoglycan remodeling activity may enhance immunotherapy and could be leveraged for next-generation adjuvants. One Sentence Summary: A conserved family of secreted NlpC/p60 peptidoglycan hydrolases from Enterococcus promote antitumor activity of immune checkpoint inhibitors.